← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Bioinvenu Corporation
Rockaway, NJ
$2,789,580
Total funding
5
Grants
Funding over time
peak $773.2K · FY2013–23$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$2,789,580 · 5
By mechanism
R44$1,540,013 · 1
R43$1,249,567 · 4
Investigators at Bioinvenu Corporation
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Novel tools for investigating GPCR-mediated 14-3-3 signaling pathway$773,235
R44 · FY2017 · MH
Novel tools for investigating GPCR-mediated 14-3-3 signaling pathway$766,778
R44 · FY2018 · MH
Novel tools for investigating GPCR-mediated 14-3-3 signaling pathway$330,536
R43 · FY2016 · MH
Screen molecules modulating MOR trafficking with a newly developed MOR/14-3-3 bioassay.$321,000
R43 · FY2019 · DA
New 5HT2AR Target Identification and Assay Development for Discovering Psychoplastogenic Compounds$319,343
R43 · FY2023 · DA
Novel tools for identifying GPCR compounds modulating specific sub-cellular ERK a$278,688
R43 · FY2013 · MH